Showing results (191-200 of 278) with videos related to
Sort By:
Pageof 28
The Journal of Experimental Medicine|June 3, 2009
The first T cell response to transmitted/founder virus contributes to the control of acute viremia in HIV-1 infectionNilu Goonetilleke, Michael K P Liu, Jesus F Salazar-Gonzalez, et al.Science Translational Medicine|October 29, 2025
Identifying correlates of viral rebound timing and viral control in SHIV-infected infant macaques after ART interruptionVeronica Obregon-Perko, Achal Awasthi, Richard Barfield, et al.Frontiers in Immunology|December 29, 2022
Fc receptor engagement of HIV-1 Env-specific antibodies in mothers and infants predicts reduced vertical transmissionBrittani M Barrows, Shelly J Krebs, Ningbo Jian, et al.Biorxiv : the Preprint Server for Biology|January 5, 2021
Lipid nanoparticle encapsulated nucleoside-modified mRNA vaccines elicit polyfunctional HIV-1 antibodies comparable to proteins in nonhuman primatesKevin O Saunders, Norbert Pardi, Robert Parks, et al.Plos One|November 11, 2024
A novel HIV triple broadly neutralizing antibody (bNAb) combination-based passive immunization of infant rhesus macaques achieves durable protective plasma neutralization levels and mediates anti-viral effector functionsSedem Dankwa, Christina Kosman, Maria Dennis, et al.The Journal of Infectious Diseases|September 25, 2021
Stable Latent HIV Infection and Low-level Viremia Despite Treatment With the Broadly Neutralizing Antibody VRC07-523LS and the Latency Reversal Agent VorinostatCynthia L Gay, Katherine S James, Marina Tuyishime, et al.Nature|January 6, 2012
Vaccine protection against acquisition of neutralization-resistant SIV challenges in rhesus monkeysDan H Barouch, Jinyan Liu, Hualin Li, et al.Vaccine|June 8, 2021
Safety and immunogenicity of an HIV-1 gp120-CD4 chimeric subunit vaccine in a phase 1a randomized controlled trialJoel V Chua, Charles Davis, Jennifer S Husson, et al.Journal of Virology|February 10, 2017
HIV/AIDS Vaccine Candidates Based on Replication-Competent Recombinant Poxvirus NYVAC-C-KC Expressing Trimeric gp140 and Gag-Derived Virus-Like Particles or Lacking the Viral Molecule B19 That Inhibits Type I Interferon Activate Relevant HIV-1-Specific B and T Cell Immune Functions in Nonhuman PrimatesJuan García-Arriaza, Beatriz Perdiguero, Jonathan L Heeney, et al.Journal of Virology|May 9, 2014
HIV-1 vaccine-induced C1 and V2 Env-specific antibodies synergize for increased antiviral activitiesJustin Pollara, Mattia Bonsignori, M Anthony Moody, et al.Pageof 28